
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A global biopharma company is offering a traineeship opportunity for Advanced Biopharmaceuticals Manufacturing Executives/Professionals in Singapore. The role involves supporting project management in site capital project implementation. Candidates should hold a Bachelor's degree in engineering and possess strong communication and problem-solving skills. It is a full-time programme aimed at developing skills for the biopharmaceutical industry with an emphasis on safety and compliance.
Site Name: Singapore - Jurong
Posted Date: Nov 7 2025
The Career Conversion Programme (CCP) (Train-and-Place with Commitment to Hire) for Advanced Biopharmaceuticals Manufacturing Executives/Professionals is a talent development programme aimed at building the next generation of manpower for Singapore’s Biopharmaceuticals manufacturing industry in anticipation of hiring demand.
The training programme consists of 15 months of local attachment with GSK. Due to the nature of the programme, we can only consider Singapore Citizens and Singapore Permanent Residents. Due to the nature of this traineeship programme, kindly note that training allowances are CPF exempted.
To assist and support engineering / project manager in the delivery of Site Capital Project implementation.
You will be based at one of our manufacturing sites in Singapore near Jurong.
Applications are now open.
Need help with your application?
Please email us at apac.earlycareers@gsk.com and let us know how we can help you.
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.